-
National Drug Code Directory recent views
The Drug Listing Act of 1972 requires registered drug establishments to provide the Food and Drug Administration (FDA) with a current list of all drugs manufactured, prepared,... -
Drugs@FDA Database recent views
Information about FDA-approved brand name and generic prescription and over-the-counter human drugs and biological therapeutic products. Drugs@FDA includes most of the drug... -
CLIA Currently Waived Analytes recent views
This database contains the commercially marketed in vitro test systems categorized as CLIA waived by the FDA since January 31, 2000, and by the Centers for Disease Control and... -
FDA Adverse Event Reporting System (FAERS): Latest Quartely Data Files recent views
The FDA Adverse Event Reporting System (FAERS) is a database that contains information on adverse event and medication error reports submitted to FDA. The database is designed... -
Drug Establishments Current Registration Site recent views
The Drug Establishments Current Registration Site (DECRS) is a database of current information submitted by drug firms to register establishments (facilities) which manufacture,... -
FDA Recognized Consensus Standards recent views
This database consists of those national and international standards recognized by FDA which manufacturers can declare conformity to and is part of the information the Center... -
Inactive ingredient Search for Approved Drug Products recent views
According to 21 CFR 210.3(b)(8), an inactive ingredient is any component of a drug product other than the active ingredient. Only inactive ingredients in the final dosage forms... -
Orange Book recent views
The Approved Drug Products with Therapeutic Equivalence (Orange Book or OB) is a list of drugs approved under Section 505 of the Federal Food, Drug and Cosmetic Act and provides... -
Current and Resolved Drug Shortages and Discontinuations Reported to FDA recent views
Information provided to FDA by manufacturers about current drugs in shortage, resolved shortages, and discontinuations of specific drug products. -
Adverse Event Reporting System (AERS) recent views
The Adverse Event Reporting System (AERS) is a computerized information database designed to support the FDA's post-marketing safety surveillance program for all approved drug... -
FDA Drug Label Data recent views
This file contains the data elements used for searching the FDA Online Data Repository including proprietary name, active ingredients, marketing application number or regulatory... -
FDA Abbott Infant Formula Recall recent views
On September 22, 2010, Abbott issued a voluntary recall of certain Similac powdered infant formula after identifying a common warehouse beetle (both larvae and adults) in the... -
NHRIC (National Health Related Items Code) recent views
The National Health Related Items Code (NHRIC) is a system for identification and numbering of marketed device packages that is compatible with other numbering systems such as... -
MDR (Medical Device Reporting) recent views
This database allows you to search the CDRH's database information on medical devices which may have malfunctioned or caused a death or serious injury during the years 1992... -
Inspection Database recent views
FDA is disclosing the final inspection classification for inspections related to currently marketed FDA-regulated products. The disclosure of this information is not intended to... -
Warning Letters recent views
An index of FDA warning letters issued to companies operating in the United States. -
FDA Acronyms and Abbreviations recent views
The FDA Acronyms and Abbreviations database provides a quick reference to acronyms and abbreviations related to Food and Drug Administration (FDA) activities -
Product Classification recent views
This database contains medical device names and associated information developed by the Center. It includes a three letter device product code and a Device Class that refers to...